Hemab Therapeutics Holdings, Inc.

COAG Healthcare Biotechnology

48.60 3.03 +6.65%
Market cap
$2.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Columns are period end dates